GlassScriptPhysician profile
Narendra Narepalem
NPI 1063495851
$11,593.32
in general payments reported to CMS, 2019-2025
48 companies · $5,254 in 2025
The $5,254 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,513 · 2020: $395 · 2021: $1,108 · 2022: $1,182 · 2023: $1,223 · 2024: $917 · 2025: $5,254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,452 · Consulting Fee: $3,300 · Travel and Lodging: $642.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,452.48 |
| Consulting Fee | $3,300.00 |
| Travel and Lodging | $641.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $4,546.94 | 2019-2025 | Erleada, Akeega |
| Intuitive Surgical, INC. | $940.99 | 2019-2023 | Da Vinci Surgical System |
| Abbvie INC. | $629.36 | 2019-2025 | |
| Astellas Pharma US INC | $490.08 | 2019-2025 | Xtandi |
| Pfizer INC. | $479.54 | 2019-2025 | |
| Antares Pharma, INC. | $412.06 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Blue Earth Diagnostics | $362.06 | 2019-2025 | Posluma |
| Olympus America INC. | $319.68 | 2022-2025 | Itind System |
| Dendreon Pharmaceuticals LLC | $277.95 | 2020-2023 | Provenge |
| Myovant Sciences INC. | $214.41 | 2021-2022 | |
| Tolmar, INC. | $209.13 | 2023-2025 | Jatenzo, Eligard |
| Merck Sharp & Dohme LLC | $179.45 | 2020-2024 | Keytruda, Lynparza, Welireg |
| Immunitybio, INC. | $162.08 | 2025 | |
| Procept Biorobotics Corporation | $158.54 | 2022-2025 | Aquabeam System |
| Coloplast Corp | $154.77 | 2019-2024 | Porges Coloplast |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Narendra Narepalem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.